Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cellcurex™ treatment increased hair growth and thickness but caused pain and bleeding.

AQB reduces harmful skin changes in systemic sclerosis.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Traumatic brain injury hospitalizations in Brazil showed specific trends and patterns from 2008 to 2021.

Online medical education helps doctors better understand and treat nail fungus.

Neural crest cells could be used in regenerative medicine due to their ability to become different cell types.

Scientists can make stem cells that can turn into any cell type.

Improving education, insurance, and support can help scarring alopecia patients access better care.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

UT-018 speeds up wound healing and boosts hair growth in mice.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

The document discusses various public health initiatives and societal issues, emphasizing early intervention and support.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

The document lists dermatology job ads across the U.S. with good pay and benefits.

AI-enhanced smart patches can personalize drug delivery for better treatment outcomes.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Dietetic-led cognitive-behavioral therapy may improve treatment for adults with ARFID.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Stinging nettle infusions improve the strength and antioxidant properties of k-carrageenan hydrogels.

Ritlecitinib works well and is safe for treating alopecia areata.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.